Significance of apparent half-lives of a metabolite with a higher elimination rate than its parent drug.

Significance of apparent half-lives of a metabolite with a higher elimination rate than its parent drug.

Drug intelligence & clinical pharmacy (1982-02-01)

T B Vree, C A Hekster, E van der Kleijn

材料

产品编号

品牌

产品描述

磺胺甲噁唑杂质A, European Pharmacopoeia (EP) Reference Standard